Database and registry research in thyroid cancer: Striving for a new and improved national thyroid cancer database

Saral Mehra, R. Michael Tuttle, Kresimira Milas, Lisa Orloff, Donald Bergman, Victor Bernet, Elise Brett, Rhoda Cobin, Gerard Doherty, Benjamin L. Judson, Joshua Klopper, Stephanie Lee, Mark Lupo, Josef Machac, Jeffrey I. Mechanick, Gregory Randolph, Douglas S. Ross, Robert Smallridge, David Terris, Ralph TufanoEran Alon, Jason Clain, Laura Dosreis, Sophie Scherl, Mark L. Urken

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Background: Health registries have become extremely powerful tools for cancer research. Unfortunately, certain details and the ability to adapt to new information are necessarily limited in current registries, and they cannot address many controversial issues in cancer management. This is of particular concern in differentiated thyroid cancer, which is rapidly increasing in incidence and has many unknowns related to optimal treatment and surveillance recommendations. Summary: In this study, we review different types of health registries used in cancer research in the United States, with a focus on their advantages and disadvantages as related to the study of thyroid cancer. This analysis includes population-based cancer registries, health systems-based cancer registries, and patient-based disease registries. It is important that clinicians understand the way data are collected in, as well as the composition of, these different registries in order to more critically interpret the clinical research that is conducted using that data. In an attempt to address shortcoming of current databases for thyroid cancer, we present the potential of an innovative web-based disease management tool for thyroid cancer called the Thyroid Cancer Care Collaborative (TCCC) to become a patient-based registry that can be used to evaluate and improve the quality of care delivered to patients with thyroid cancer as well as to answer questions that we have not been able to address with current databases and registries. Conclusion: A cancer registry that follows a specific patient, is integrated into physician workflow, and collects data across different treatment sites and different payers does not exist in the current fragmented system of healthcare in the United States. The TCCC offers physicians who treat thyroid cancer numerous time-saving and quality improvement services, and could significantly improve patient care. With rapid adoption across the nation, the TCCC could become a new paradigm for database research in thyroid cancer to improve our understanding of thyroid cancer management.

    Original languageEnglish (US)
    Pages (from-to)157-168
    Number of pages12
    JournalThyroid
    Volume25
    Issue number2
    DOIs
    StatePublished - Feb 1 2015

    Fingerprint

    Thyroid Neoplasms
    Registries
    Databases
    Research
    Neoplasms
    Health
    Physicians
    Workflow
    Quality of Health Care
    Disease Management
    Quality Improvement
    Patient Care
    Delivery of Health Care

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism
    • Medicine(all)

    Cite this

    Mehra, S., Tuttle, R. M., Milas, K., Orloff, L., Bergman, D., Bernet, V., ... Urken, M. L. (2015). Database and registry research in thyroid cancer: Striving for a new and improved national thyroid cancer database. Thyroid, 25(2), 157-168. https://doi.org/10.1089/thy.2014.0270

    Database and registry research in thyroid cancer : Striving for a new and improved national thyroid cancer database. / Mehra, Saral; Tuttle, R. Michael; Milas, Kresimira; Orloff, Lisa; Bergman, Donald; Bernet, Victor; Brett, Elise; Cobin, Rhoda; Doherty, Gerard; Judson, Benjamin L.; Klopper, Joshua; Lee, Stephanie; Lupo, Mark; Machac, Josef; Mechanick, Jeffrey I.; Randolph, Gregory; Ross, Douglas S.; Smallridge, Robert; Terris, David; Tufano, Ralph; Alon, Eran; Clain, Jason; Dosreis, Laura; Scherl, Sophie; Urken, Mark L.

    In: Thyroid, Vol. 25, No. 2, 01.02.2015, p. 157-168.

    Research output: Contribution to journalArticle

    Mehra, S, Tuttle, RM, Milas, K, Orloff, L, Bergman, D, Bernet, V, Brett, E, Cobin, R, Doherty, G, Judson, BL, Klopper, J, Lee, S, Lupo, M, Machac, J, Mechanick, JI, Randolph, G, Ross, DS, Smallridge, R, Terris, D, Tufano, R, Alon, E, Clain, J, Dosreis, L, Scherl, S & Urken, ML 2015, 'Database and registry research in thyroid cancer: Striving for a new and improved national thyroid cancer database', Thyroid, vol. 25, no. 2, pp. 157-168. https://doi.org/10.1089/thy.2014.0270
    Mehra, Saral ; Tuttle, R. Michael ; Milas, Kresimira ; Orloff, Lisa ; Bergman, Donald ; Bernet, Victor ; Brett, Elise ; Cobin, Rhoda ; Doherty, Gerard ; Judson, Benjamin L. ; Klopper, Joshua ; Lee, Stephanie ; Lupo, Mark ; Machac, Josef ; Mechanick, Jeffrey I. ; Randolph, Gregory ; Ross, Douglas S. ; Smallridge, Robert ; Terris, David ; Tufano, Ralph ; Alon, Eran ; Clain, Jason ; Dosreis, Laura ; Scherl, Sophie ; Urken, Mark L. / Database and registry research in thyroid cancer : Striving for a new and improved national thyroid cancer database. In: Thyroid. 2015 ; Vol. 25, No. 2. pp. 157-168.
    @article{469dd13889234e43a13ce712480e2086,
    title = "Database and registry research in thyroid cancer: Striving for a new and improved national thyroid cancer database",
    abstract = "Background: Health registries have become extremely powerful tools for cancer research. Unfortunately, certain details and the ability to adapt to new information are necessarily limited in current registries, and they cannot address many controversial issues in cancer management. This is of particular concern in differentiated thyroid cancer, which is rapidly increasing in incidence and has many unknowns related to optimal treatment and surveillance recommendations. Summary: In this study, we review different types of health registries used in cancer research in the United States, with a focus on their advantages and disadvantages as related to the study of thyroid cancer. This analysis includes population-based cancer registries, health systems-based cancer registries, and patient-based disease registries. It is important that clinicians understand the way data are collected in, as well as the composition of, these different registries in order to more critically interpret the clinical research that is conducted using that data. In an attempt to address shortcoming of current databases for thyroid cancer, we present the potential of an innovative web-based disease management tool for thyroid cancer called the Thyroid Cancer Care Collaborative (TCCC) to become a patient-based registry that can be used to evaluate and improve the quality of care delivered to patients with thyroid cancer as well as to answer questions that we have not been able to address with current databases and registries. Conclusion: A cancer registry that follows a specific patient, is integrated into physician workflow, and collects data across different treatment sites and different payers does not exist in the current fragmented system of healthcare in the United States. The TCCC offers physicians who treat thyroid cancer numerous time-saving and quality improvement services, and could significantly improve patient care. With rapid adoption across the nation, the TCCC could become a new paradigm for database research in thyroid cancer to improve our understanding of thyroid cancer management.",
    author = "Saral Mehra and Tuttle, {R. Michael} and Kresimira Milas and Lisa Orloff and Donald Bergman and Victor Bernet and Elise Brett and Rhoda Cobin and Gerard Doherty and Judson, {Benjamin L.} and Joshua Klopper and Stephanie Lee and Mark Lupo and Josef Machac and Mechanick, {Jeffrey I.} and Gregory Randolph and Ross, {Douglas S.} and Robert Smallridge and David Terris and Ralph Tufano and Eran Alon and Jason Clain and Laura Dosreis and Sophie Scherl and Urken, {Mark L.}",
    year = "2015",
    month = "2",
    day = "1",
    doi = "10.1089/thy.2014.0270",
    language = "English (US)",
    volume = "25",
    pages = "157--168",
    journal = "Thyroid",
    issn = "1050-7256",
    publisher = "Mary Ann Liebert Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Database and registry research in thyroid cancer

    T2 - Striving for a new and improved national thyroid cancer database

    AU - Mehra, Saral

    AU - Tuttle, R. Michael

    AU - Milas, Kresimira

    AU - Orloff, Lisa

    AU - Bergman, Donald

    AU - Bernet, Victor

    AU - Brett, Elise

    AU - Cobin, Rhoda

    AU - Doherty, Gerard

    AU - Judson, Benjamin L.

    AU - Klopper, Joshua

    AU - Lee, Stephanie

    AU - Lupo, Mark

    AU - Machac, Josef

    AU - Mechanick, Jeffrey I.

    AU - Randolph, Gregory

    AU - Ross, Douglas S.

    AU - Smallridge, Robert

    AU - Terris, David

    AU - Tufano, Ralph

    AU - Alon, Eran

    AU - Clain, Jason

    AU - Dosreis, Laura

    AU - Scherl, Sophie

    AU - Urken, Mark L.

    PY - 2015/2/1

    Y1 - 2015/2/1

    N2 - Background: Health registries have become extremely powerful tools for cancer research. Unfortunately, certain details and the ability to adapt to new information are necessarily limited in current registries, and they cannot address many controversial issues in cancer management. This is of particular concern in differentiated thyroid cancer, which is rapidly increasing in incidence and has many unknowns related to optimal treatment and surveillance recommendations. Summary: In this study, we review different types of health registries used in cancer research in the United States, with a focus on their advantages and disadvantages as related to the study of thyroid cancer. This analysis includes population-based cancer registries, health systems-based cancer registries, and patient-based disease registries. It is important that clinicians understand the way data are collected in, as well as the composition of, these different registries in order to more critically interpret the clinical research that is conducted using that data. In an attempt to address shortcoming of current databases for thyroid cancer, we present the potential of an innovative web-based disease management tool for thyroid cancer called the Thyroid Cancer Care Collaborative (TCCC) to become a patient-based registry that can be used to evaluate and improve the quality of care delivered to patients with thyroid cancer as well as to answer questions that we have not been able to address with current databases and registries. Conclusion: A cancer registry that follows a specific patient, is integrated into physician workflow, and collects data across different treatment sites and different payers does not exist in the current fragmented system of healthcare in the United States. The TCCC offers physicians who treat thyroid cancer numerous time-saving and quality improvement services, and could significantly improve patient care. With rapid adoption across the nation, the TCCC could become a new paradigm for database research in thyroid cancer to improve our understanding of thyroid cancer management.

    AB - Background: Health registries have become extremely powerful tools for cancer research. Unfortunately, certain details and the ability to adapt to new information are necessarily limited in current registries, and they cannot address many controversial issues in cancer management. This is of particular concern in differentiated thyroid cancer, which is rapidly increasing in incidence and has many unknowns related to optimal treatment and surveillance recommendations. Summary: In this study, we review different types of health registries used in cancer research in the United States, with a focus on their advantages and disadvantages as related to the study of thyroid cancer. This analysis includes population-based cancer registries, health systems-based cancer registries, and patient-based disease registries. It is important that clinicians understand the way data are collected in, as well as the composition of, these different registries in order to more critically interpret the clinical research that is conducted using that data. In an attempt to address shortcoming of current databases for thyroid cancer, we present the potential of an innovative web-based disease management tool for thyroid cancer called the Thyroid Cancer Care Collaborative (TCCC) to become a patient-based registry that can be used to evaluate and improve the quality of care delivered to patients with thyroid cancer as well as to answer questions that we have not been able to address with current databases and registries. Conclusion: A cancer registry that follows a specific patient, is integrated into physician workflow, and collects data across different treatment sites and different payers does not exist in the current fragmented system of healthcare in the United States. The TCCC offers physicians who treat thyroid cancer numerous time-saving and quality improvement services, and could significantly improve patient care. With rapid adoption across the nation, the TCCC could become a new paradigm for database research in thyroid cancer to improve our understanding of thyroid cancer management.

    UR - http://www.scopus.com/inward/record.url?scp=84922558757&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84922558757&partnerID=8YFLogxK

    U2 - 10.1089/thy.2014.0270

    DO - 10.1089/thy.2014.0270

    M3 - Article

    C2 - 25517683

    AN - SCOPUS:84922558757

    VL - 25

    SP - 157

    EP - 168

    JO - Thyroid

    JF - Thyroid

    SN - 1050-7256

    IS - 2

    ER -